diltiazem has been researched along with s-nitroso-n-acetylpenicillamine in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (75.00) | 18.2507 |
| 2000's | 1 (25.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Holtzclaw, L; Klein, DC; Rodriguez, IR; Russell, JT; Schaad, NC; Vanecek, J | 1 |
| Hensel, M; Kox, WJ; Mäding, K; Volk, T | 1 |
| Duszyk, M; Thethi, K | 1 |
| Hintze, TH; Kaley, G; Loke, KE; Messina, EJ; Shesely, EG | 1 |
4 other study(ies) available for diltiazem and s-nitroso-n-acetylpenicillamine
| Article | Year |
|---|---|
Vasoactive intestinal peptide elevates pinealocyte intracellular calcium concentrations by enhancing influx: evidence for involvement of a cyclic GMP-dependent mechanism.
Topics: Animals; Calcium; Cells, Cultured; Cyclic GMP; Diltiazem; Extracellular Space; Intracellular Fluid; Ion Channels; Ion Transport; Norepinephrine; Nucleotides, Cyclic; Penicillamine; Pineal Gland; Rats; Receptors, Vasoactive Intestinal Peptide; RNA, Messenger; S-Nitroso-N-Acetylpenicillamine; Vasoactive Intestinal Peptide | 1995 |
Nitric oxide induces transient Ca2+ changes in endothelial cells independent of cGMP.
Topics: Adenosine Triphosphate; Caffeine; Calcium; Cell Line; Cyclic GMP; Dantrolene; Diltiazem; Endothelium, Vascular; Enzyme Activation; Guanylate Cyclase; Humans; Indoles; Inositol 1,4,5-Trisphosphate; Nitric Oxide; Nitroprusside; Penicillamine; Procaine; Ryanodine; S-Nitroso-N-Acetylpenicillamine; Thapsigargin | 1997 |
Nitric oxide inhibits whole-cell current in cystic fibrosis pancreatic epithelial cells.
Topics: 4,4'-Diisothiocyanostilbene-2,2'-Disulfonic Acid; Amiloride; Calcium Channel Blockers; Cell Line; Charybdotoxin; Cyclic AMP; Cyclic GMP; Cystic Fibrosis; Diltiazem; Enzyme Inhibitors; Epithelial Cells; Glutathione; Humans; Membrane Potentials; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Donors; Nitroso Compounds; Oxadiazoles; Pancreas; Patch-Clamp Techniques; Penicillamine; Quinoxalines; S-Nitroso-N-Acetylpenicillamine; S-Nitrosoglutathione | 1999 |
Potential role of eNOS in the therapeutic control of myocardial oxygen consumption by ACE inhibitors and amlodipine.
Topics: Amlodipine; Angiotensin-Converting Enzyme Inhibitors; Animals; Calcium Channel Blockers; Carbachol; Cardiotonic Agents; Culture Techniques; Diltiazem; Dose-Response Relationship, Drug; Female; Male; Mice; Mice, Inbred C57BL; Myocardium; Nitric Oxide Donors; Nitric Oxide Synthase; Oxygen Consumption; Ramipril; S-Nitroso-N-Acetylpenicillamine; Substance P; Vasodilator Agents | 2001 |